IDEXX LABORATORIES INC /DE (IDXX) Financials
Annual revenue, profitability and per-share results for IDEXX LABORATORIES INC /DE, as reported in SEC filings.
Revenue · FY2025
$4.30B
▲ 10.4%YoY
Net income · FY2025
$1.06B
▲ 19.3%YoY
Gross margin · FY2025
61.8%
Diluted EPS · FY2025
$13.08
▲ 22.6%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $4.30B | $1.06B | $2.66B | $13.08 | $1.06B | 31.6% | +10.4% |
| FY2024 | $3.90B | $887.87M | $2.38B | $10.67 | $808.08M | 28.9% | +6.5% |
| FY2023 | $3.66B | $845.04M | $2.19B | $10.06 | $772.88M | 30.0% | +8.7% |
| FY2022 | $3.37B | $679.09M | $2.00B | $8.03 | $394.15M | 26.7% | +4.7% |
Figures as reported in IDEXX LABORATORIES INC /DE's 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a IDXX filing.
Get an email when IDXX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.